Android app on Google Play

Pernix Therapeutics (PTX) Shares Spike - Acquires Great Southern Labs and Looking For More

July 3, 2012 10:22 AM EDT Send to a Friend
Get Alerts PTX Hot Sheet
Price: $4.70 --0%

Rating Summary:
    4 Buy, 3 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 0 | Down: 0 | New: 0
Trade PTX Now!
Join SI Premium – FREE
Shares of Pernix Therapeutics (NYSE: PTX) are up trading higher this morning, maybe with help from Canaccord Genuity comments. The stock has been on a little bit of a rally, gaining over 13% in the past five trading sessions.

Canaccord analyst, Randall Stanicky, reiterated his 'Buy' rating this morning with a $14 price target.

Stanicky sees PTX staying active in with tuck-in acquisitions, citing the recent announcement PTX bought Great Southern Labs for $4.9 million. PTX has a diverse revenue stream and $39 million in the bank, so expect the company to remain active on the business development front.

The stock is currently trading at $7.77...the 52-wk trading range is $5.90-11.50. However, volume is relatively light.

To see more ratings on PTX, Click Here




You May Also Be Interested In


Related Categories

Analyst Comments, Mergers and Acquisitions

Related Entities

Canaccord Genuity

Add Your Comment